Judge Invalidates Allergan's Patent With SRMT

Four of the company’s patents covering its blockbuster eye drug Restasis were ruled invalid on Monday, October 16, 2017, by the US District Court for the Eastern District of Texas.

According to NPR, in the order on the agreement between Allergan and...